Drug
Pyridoxal 5
Pyridoxal 5: highest development phase Phase 3, developed by Medicure. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Medicure
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pyridoxal 5'-Phosphate NCT07928388 | Phase 3 | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency |
Latest
No recent events.
Follow Pyridoxal 5 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.